Access to anti-retroviral drugs, female in Bhutan
Bhutan: Access to anti-retroviral drugs, female was 80.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Bhutan, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in Bhutan is 80.0%, measured in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 5.3% on the previous year and up 95.1% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Bhutan peaked at 80.0% in 2024 and was at its lowest, 0.0%, in 2000.
Bhutan ranks 57th of 141 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Bhutan, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 3.0% | — |
| 2006 | 5.0% | +66.7% |
| 2007 | 7.0% | +40.0% |
| 2008 | 11.0% | +57.1% |
| 2009 | 14.0% | +27.3% |
| 2010 | 18.0% | +28.6% |
| 2011 | 23.0% | +27.8% |
| 2012 | 30.0% | +30.4% |
| 2013 | 37.0% | +23.3% |
| 2014 | 41.0% | +10.8% |
| 2015 | 51.0% | +24.4% |
| 2016 | 56.0% | +9.8% |
| 2017 | 66.0% | +17.9% |
| 2018 | 71.0% | +7.6% |
| 2019 | 69.0% | -2.8% |
| 2020 | 71.0% | +2.9% |
| 2021 | 72.0% | +1.4% |
| 2022 | 75.0% | +4.2% |
| 2023 | 76.0% | +1.3% |
| 2024 | 80.0% | +5.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 4.0% | 0.0% | 14.0% | 10 |
| 2010s | 46.2% | 18.0% | 71.0% | 10 |
| 2020s | 74.8% | 71.0% | 80.0% | 5 |
Countries ranked near Bhutan
More gender data for Bhutan
- Child population (UN estimates and projections) 147.07 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -1.49 % change on previous year (2030)
- Population 673.62 (2030)
- Working-age population (UN estimates and projections) 673.62 (2030)
- Population (UN estimates and projections), annual growth rate 0.997 % change on previous year (2030)
- Age population, age 00, female, interpolated 4,751 (2025)
- Age population, age 00, male, interpolated 4,967 (2025)
- Age population, age 01, female, interpolated 4,765 (2025)
- Age population, age 01, male, interpolated 4,981 (2025)
- Age population, age 02, female, interpolated 4,779 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Bhutan?
- Access to anti-retroviral drugs, female in Bhutan was 80.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Bhutan?
- The highest recorded value was 80.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Bhutan?
- The lowest recorded value was 0.0% in 2000.
- How does Bhutan rank for access to anti-retroviral drugs, female?
- Bhutan ranks 57th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Bhutan?
- Over the last ten years it is up 95.1%. The long-run trend across the full record is volatile.
- Where does this Bhutan data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.